Most medical imaging happens after a symptom, injury, or abnormal test gives a clinician a reason to look. But what changes if imaging becomes a more routine measurement, creating a record of the body before something goes wrong? In this episode of Next Level, Mike Haney talks with Dr. Daniel Durand, chief medical officer at Prenuvo, about whole-body MRI as a test case for a broader shift from episodic medicine toward longitudinal health data. Whole-body MRI is controversial, and Durand is clearly an advocate. The conversation takes the skepticism seriously, then asks a larger question: as measurement gets cheaper, more frequent, and increasingly visible to patients themselves, how should medicine decide what is worth knowing? Free course: Improve your metabolic health Get our free email course on how glucose, nutrition, exercise, sleep, and measurement can help you build habits that support better energy and long-term health: https://levels.link/wnl What We Cover: How X-rays, CT scans, ultrasound, and MRI differ, and why radiation matters when you start thinking about repeated imagingWhat whole-body MRI sees well, and where CT, colonoscopy, or blood-based approaches may still be betterThe concerns around incidental findings, overdiagnosis, anxiety, and unnecessary follow-up, and Durand’s response to themWhat the current cancer-detection evidence for whole-body MRI does, and does not, establishWhy having prior scans could help distinguish a stable abnormality from something genuinely newHow faster scans and AI interpretation could eventually connect imaging with genomic, proteomic, and other health data 🎙️ About the Guest: Dr. Daniel Durand is chief medical officer at Prenuvo and president of the Prenuvo Medical Group. He trained at Johns Hopkins, is board-certified in adult and pediatric radiology, and previously served as chief clinical officer and chief innovation officer at LifeBridge Health. 📍What Dr. Daniel Durand & Mike Haney discussed: 03:32 - Why imaging belongs in a series about continuous measurement15:32 - Imaging 101: X-rays, CT, ultrasound, and MRI28:57 - How AI is shortening MRI scan times38:52 - Screening versus surveillance40:26 - Which cancers whole-body MRI can miss46:39 - The case against scanning healthy people52:40 - What the cancer-detection data actually shows54:39 - "We're all going to get a body scan"1:03:31 - What would make routine imaging more useful?1:11:49 - Building a baseline of the healthy body1:17:43 - When AI can see more than a radiologist1:21:28 - Is it better to know, even when you can't treat it? 🔗 Helpful Links: Dr. Daniel Durand, Prenuvo: Prenuvo medical leadershipMeta-analysis behind the ~9,000 participants and ~1.6% detection figures. It notes limits, including incidental findings (European Radiology, 2026): PubMedPrenuvo-associated study of 1,011 people, 2.2% confirmed cancer detection (Cancer Research/AACR, 2025): AACR abstractIncidental findings in whole-body MRI and their psychosocial effects (European Journal of Radiology, 2021): PubMedPrenuvo's research overview, including Polaris data (company-reported): Prenuvo clinical research Watch the conversation: https://youtu.be/rFZVbzUPSaA Find us on YouTube: https://youtube.com/levelshealth?sub_confirmation=1 📲 Connect: Connect with Dr. Daniel Durand at LinkedIn 👋 Who we are: Levels helps you understand your metabolic health with personalized data, expert guidance, and tools that connect your daily choices to measurable changes in your body. Our goal is to help you make better decisions about food, exercise, sleep, and long-term health. Look for new shows every month on A Whole New Level, where we have in-depth conversations with thought leaders about metabolic health.
